Glaxo asthma drug clears key hurdle in Europe
LONDON–GlaxoSmithKline PLC's [GSK.LN] new severe-asthma medicine has received a positive opinion from the scientific committee of the European Medicines Agency for use in adults, clearing a key hurdle towards gaining marketing approval in Europe.
EU regulator backs approval for GSK injectable asthma drug
GlaxoSmithKline plc (ADR) To Lead Asthma Market
GlaxoSmithKline's asthma injection heads for EU approval
View full post on asthma – Google News